The startup develops a novel asymmetrical linear stapler for minimally invasive surgery that facilitates tissue sampling for frozen section biopsy from the true resection margin. This technology enables intraoperative confirmation of cancer surgery radicality, improving surgical efficiency and patient outcomes.
Funding
$16.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
During minimally invasive cancer surgery, surgeons face challenges in accurately assessing the radicality of the resection margin in real-time. Current methods often require additional procedures or delay, hindering surgical efficiency and potentially impacting patient outcomes due to undetected residual cancer cells.
Solution
Meditulip has developed an asymmetrical linear stapler designed for minimally invasive surgery, enabling surgeons to obtain tissue samples for frozen section biopsy directly from the true resection margin. This technology facilitates intraoperative pathological confirmation of cancer surgery radicality, ensuring that no cancer cells remain at the surgical site. The stapler's unique asymmetrical design allows for precise tissue acquisition without compromising the integrity of the remaining tissue. By providing immediate feedback on the completeness of tumor removal, Meditulip's stapler improves surgical precision, reduces the need for secondary procedures, and enhances the overall effectiveness of cancer surgery. The device is available in multiple sizes to accommodate various surgical needs.
Target Audience
The primary target audience includes surgeons specializing in minimally invasive cancer surgery, pathologists requiring immediate tissue samples for analysis, and hospitals seeking to improve surgical outcomes and efficiency.
Features
- Asymmetrical staple design for simultaneous resection and tissue sampling
- Facilitates frozen section biopsy from the true resection margin
- Enables intraoperative confirmation of cancer surgery radicality
- Compatible with minimally invasive surgical techniques
- Available in various sizes (60mm, 45mm, 30mm)
- Cartridge options for different tissue thicknesses (thick, medium, vascular/thin)
- Color-coded cartridges for easy identification of staple height
- Korean articulating endoscopic stapler
- Patented endoscopic stapler of asymmetric structure